Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer
Clinical trial NCT06363006 · RECRUITING
Trial details
- NCT number
- NCT06363006
- Sponsor
- Peking Union Medical College Hospital
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-11
- Primary completion
- 2026-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.